EryPharm Alternatives & Competitors
12 companies similar to EryPharm — EryPharm developed a mass production process for cultured red blood cells as a t...
Companies similar to EryPharm
OXYVITA Inc.
Experience a clinically useful blood substitute that dramatically reduces reliance on huma...
New Windsor, United State...
Fuji Systems Corporation
Fuji Systems, established in 1963, is a company to development and production of medical d...
Japan
Neuralstem, Inc.
Advancing stem cell technology to treat central nervous system diseases and deliver hope f...
Rival Readout
Competing with EryPharm? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
TRELYS
Driving innovation in biotechnology since 2012 with roots in San Francisco, California
Khloris Biosciences
Pioneering medical treatment using advanced stem cell technology to address critical cardi...
Azenta Life Sciences
Unrivaled sample exploration and management that helps life science companies bring impact...
Burlington, United States
InVenis Biotherapies
Platelet-derived Regenerative Therapy for CNS Disorders
Loos, France
InDevR, Inc.
InDevR is a global leader in progressive new analytical technologies for vaccines and othe...
Boulder, United States
Shanghai, China
INDIGO Biosciences, INC
In Vitro Assay Solutions That Work Simply And Simply Work
State College, United Sta...
About EryPharm
EryPharm, founded in 2016, is a pioneering biotech startup headquartered in France. The company has developed an innovative large-scale process for producing cultured red blood cells from stem cells, a project initially spearheaded by Dr. Luc Douay and his team at the Paris Sorbonne University.
Mass production of cultured red blood cells, Development of new blood transfusion products, Innovative biotechnological approaches
Patients with hereditary blood disorders, Cancer patients requiring multiple transfusions, Healthcare providers, Medical research facilities
Biotech, Stem Cell Technology, Blood Transfusion, Cultured Red Blood Cells, Therapeutic Products, Medical Innovation, Biomedical Engineering, Life Sciences, Research And Development
B2B, B2D, B2G
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around EryPharm: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at EryPharm on 7 Jun 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 5 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
